PTEN and cancer: According to studies, downregulation of the PI3K/AKT/mTOR pathway can enhance ferroptosis induction in cancer cells, especially those with PI3K mutations or PTEN deficiency, by downregulating downstream factors such as GPX4, SREBP1, and SLC7A11.